Xtl Biopharmaceuticals Ltd Stock Price History
| XTLB Stock | USD 2.10 0.22 11.70% |
Below is the normalized historical share price chart for XTL Biopharmaceuticals Ltd extending back to September 01, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of XTL Biopharmaceutica stands at 2.10, as last reported on the 26th of December, with the highest price reaching 2.10 and the lowest price hitting 1.72 during the day.
If you're considering investing in XTL Stock, it is important to understand the factors that can impact its price. XTL Biopharmaceuticals shows Sharpe Ratio of -0.0023, which attests that the company had a -0.0023% return per unit of standard deviation over the last 3 months. XTL Biopharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out XTL Biopharmaceutica's insignificant Risk Adjusted Performance, standard deviation of 7.53, and Mean Deviation of 4.7 to validate the risk estimate we provide.
At present, XTL Biopharmaceutica's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 15.9 M, whereas Total Stockholder Equity is forecasted to decline to about 2.1 M. . At present, XTL Biopharmaceutica's Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 30.04, whereas Price To Sales Ratio is forecasted to decline to 0.15. XTL Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of September 2005 | 200 Day MA 2.3287 | 50 Day MA 1.8262 | Beta 0.996 |
XTL |
Sharpe Ratio = -0.0023
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | XTLB |
Estimated Market Risk
| 7.75 actual daily | 69 69% of assets are less volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average XTL Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XTL Biopharmaceutica by adding XTL Biopharmaceutica to a well-diversified portfolio.
Price Book 3.7871 | Book Value 0.005 | Enterprise Value 6.4 M | Enterprise Value Ebitda 10.2134 | Shares Float 487.7 M |
XTL Biopharmaceutica Stock Price History Chart
There are several ways to analyze XTL Stock price data. The simplest method is using a basic XTL candlestick price chart, which shows XTL Biopharmaceutica price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 3, 2024 | 2.4 |
| Lowest Price | October 23, 2024 | 1.39 |
XTL Biopharmaceutica December 26, 2024 Stock Price Synopsis
Various analyses of XTL Biopharmaceutica's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell XTL Stock. It can be used to describe the percentage change in the price of XTL Biopharmaceutica from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of XTL Stock.| XTL Biopharmaceutica Accumulation Distribution | 7,677 | |
| XTL Biopharmaceutica Price Daily Balance Of Power | 0.58 | |
| XTL Biopharmaceutica Price Action Indicator | 0.30 | |
| XTL Biopharmaceutica Price Rate Of Daily Change | 1.12 |
XTL Biopharmaceutica December 26, 2024 Stock Price Analysis
XTL Stock Price History Data
The price series of XTL Biopharmaceutica for the period between Fri, Sep 27, 2024 and Thu, Dec 26, 2024 has a statistical range of 1.2 with a coefficient of variation of 14.93. The daily prices for the period are distributed with arithmetic mean of 1.95. The median price for the last 90 days is 1.88. The company experienced 1:5 stock split on 10th of February 2017. XTL Biopharmaceuticals paid out dividends to its shareholders on 2017-02-10.| Open | High | Low | Close | Volume | ||
| 12/26/2024 | 1.72 | 2.10 | 1.72 | 2.10 | 42,428 | |
| 12/26/2024 | 1.72 | 2.10 | 1.72 | 2.10 | 42,428 | |
| 12/24/2024 | 1.72 | 1.88 | 1.57 | 1.88 | 1,091 | |
| 12/23/2024 | 1.58 | 1.76 | 1.58 | 1.76 | 1,600 | |
| 12/20/2024 | 1.45 | 1.50 | 1.43 | 1.44 | 2,698 | |
| 12/19/2024 | 1.46 | 1.48 | 1.42 | 1.46 | 3,315 | |
| 12/18/2024 | 1.55 | 1.55 | 1.46 | 1.49 | 15,700 | |
| 12/17/2024 | 1.64 | 1.65 | 1.55 | 1.57 | 10,227 | |
| 12/16/2024 | 1.70 | 1.70 | 1.61 | 1.67 | 18,912 | |
| 12/13/2024 | 1.81 | 1.83 | 1.76 | 1.80 | 1,247 | |
| 12/12/2024 | 1.80 | 1.81 | 1.80 | 1.81 | 1,338 | |
| 12/11/2024 | 1.72 | 1.80 | 1.63 | 1.80 | 28,941 | |
| 12/10/2024 | 1.67 | 1.76 | 1.66 | 1.70 | 5,796 | |
| 12/09/2024 | 1.88 | 1.88 | 1.63 | 1.73 | 52,432 | |
| 12/06/2024 | 1.87 | 1.95 | 1.78 | 1.94 | 16,772 | |
| 12/05/2024 | 1.89 | 2.06 | 1.89 | 1.97 | 17,910 | |
| 12/04/2024 | 1.83 | 2.05 | 1.82 | 1.95 | 30,237 | |
| 12/03/2024 | 1.82 | 1.93 | 1.81 | 1.91 | 12,675 | |
| 12/02/2024 | 1.86 | 1.86 | 1.81 | 1.85 | 2,983 | |
| 11/29/2024 | 1.82 | 1.89 | 1.78 | 1.88 | 3,500 | |
| 11/27/2024 | 1.75 | 1.85 | 1.75 | 1.85 | 10,000 | |
| 11/26/2024 | 1.85 | 1.90 | 1.70 | 1.85 | 7,399 | |
| 11/25/2024 | 1.73 | 1.88 | 1.72 | 1.88 | 12,700 | |
| 11/22/2024 | 1.75 | 1.88 | 1.69 | 1.88 | 2,835 | |
| 11/21/2024 | 1.67 | 1.83 | 1.67 | 1.83 | 6,083 | |
| 11/20/2024 | 1.77 | 1.77 | 1.70 | 1.77 | 2,200 | |
| 11/19/2024 | 1.70 | 1.85 | 1.70 | 1.77 | 1,109 | |
| 11/18/2024 | 1.82 | 1.82 | 1.75 | 1.75 | 2,505 | |
| 11/15/2024 | 1.82 | 1.85 | 1.72 | 1.85 | 21,260 | |
| 11/14/2024 | 1.85 | 1.85 | 1.80 | 1.82 | 4,316 | |
| 11/13/2024 | 1.87 | 1.87 | 1.87 | 1.87 | 374.00 | |
| 11/12/2024 | 1.83 | 1.96 | 1.77 | 1.87 | 29,764 | |
| 11/11/2024 | 1.79 | 1.83 | 1.70 | 1.76 | 6,486 | |
| 11/08/2024 | 1.84 | 1.84 | 1.73 | 1.84 | 2,083 | |
| 11/07/2024 | 1.85 | 1.91 | 1.77 | 1.86 | 8,627 | |
| 11/06/2024 | 1.77 | 1.85 | 1.73 | 1.81 | 11,676 | |
| 11/05/2024 | 1.77 | 1.94 | 1.74 | 1.82 | 22,939 | |
| 11/04/2024 | 2.04 | 2.04 | 1.82 | 1.88 | 53,600 | |
| 11/01/2024 | 2.21 | 2.38 | 2.10 | 2.35 | 73,807 | |
| 10/31/2024 | 1.73 | 2.28 | 1.69 | 2.24 | 144,745 | |
| 10/30/2024 | 1.70 | 1.84 | 1.65 | 1.78 | 14,716 | |
| 10/29/2024 | 1.74 | 1.79 | 1.64 | 1.74 | 70,100 | |
| 10/28/2024 | 1.56 | 2.23 | 1.29 | 1.90 | 1,681,539 | |
| 10/25/2024 | 1.49 | 1.56 | 1.49 | 1.55 | 11,906 | |
| 10/24/2024 | 1.49 | 1.58 | 1.32 | 1.47 | 19,080 | |
| 10/23/2024 | 1.79 | 1.80 | 1.37 | 1.39 | 74,256 | |
| 10/22/2024 | 1.94 | 1.94 | 1.81 | 1.81 | 2,219 | |
| 10/21/2024 | 1.92 | 1.98 | 1.91 | 1.96 | 9,340 | |
| 10/18/2024 | 2.10 | 2.17 | 1.98 | 2.09 | 14,850 | |
| 10/17/2024 | 2.18 | 2.18 | 2.16 | 2.17 | 4,291 | |
| 10/16/2024 | 2.05 | 2.19 | 1.98 | 1.98 | 6,396 | |
| 10/15/2024 | 2.23 | 2.28 | 1.99 | 1.99 | 9,550 | |
| 10/14/2024 | 2.20 | 2.20 | 2.20 | 2.20 | 400.00 | |
| 10/11/2024 | 2.23 | 2.50 | 2.12 | 2.20 | 18,199 | |
| 10/10/2024 | 2.22 | 2.26 | 2.17 | 2.17 | 2,394 | |
| 10/09/2024 | 2.24 | 2.24 | 2.15 | 2.19 | 2,606 | |
| 10/08/2024 | 2.30 | 2.30 | 2.22 | 2.22 | 4,502 | |
| 10/07/2024 | 2.25 | 2.36 | 2.24 | 2.30 | 11,489 | |
| 10/04/2024 | 2.39 | 2.39 | 2.35 | 2.35 | 1,200 | |
| 10/03/2024 | 2.41 | 2.42 | 2.40 | 2.40 | 2,400 | |
| 10/02/2024 | 2.35 | 2.42 | 2.28 | 2.33 | 10,259 |
About XTL Biopharmaceutica Stock history
XTL Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XTL is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XTL Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XTL Biopharmaceutica stock prices may prove useful in developing a viable investing in XTL Biopharmaceutica
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 544.9 M | 572.2 M | |
| Net Loss | -1.6 M | -1.6 M |
XTL Biopharmaceutica Quarterly Net Working Capital |
|
XTL Biopharmaceutica Stock Technical Analysis
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
XTL Biopharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for XTL Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of XTL Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XTL to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.44) | |||
| Treynor Ratio | (0.08) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |